Chester County News and Community Website
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced that its Chief Executive Officer, Maria Maccecchini, Ph.D., will present at the Oppenheimer’s 35th Annual Healthcare Life Sciences Conference on February …
Annovis Bio CEO to Present at Oppenheimer Healthcare Life Sciences Conference Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) today announced the pricing of its underwritten public offering of 8,000,000 shares of common stock at $2.25 per share. The offering is expected …
Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share Read More MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has announced the completion this week of its underwritten public offering, generating $21 million in gross proceeds. The offering consisted of 5,250,000 shares …
Annovis Bio Raises $21 Million in Public Offering to Advance Alzheimer’s Research Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced that Matthew Barnes, the company’s senior director of portfolio management, will be presenting at the Outsourcing in Clinical Trials (OCT) Conference. …
Virpax Pharmaceuticals Highlights Leadership Contributions at Clinical Trial Conference Read More
EXTON, PA — Innovative Solutions & Support, Inc. (NASDAQ: ISSC) has announced the appointment of Denise L. Devine, CPA, MBA, MST, as an independent director to its Board of Directors. Effective …
Innovative Solutions & Support Appoints Denise L. Devine to Board of Directors Read More MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has revealed plans to conduct an underwritten public offering of common stock and warrants. The company will sell all offered securities directly, with …
Annovis Bio Announces Public Offering of Common Stock and Warrants Read More
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share.
West Pharmaceutical Services Declares Q1 2025 Dividend Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the creation of its new Scientific Advisory Board (SAB), marking a strategic step in advancing its focus on immuno-inflammatory diseases. The …
Aclaris Therapeutics Forms Scientific Advisory Board with Renowned Pulmonology Experts Read More